The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Combs Andrew since 2020.
This trader's CIK number is 1825005.
At the time of last reporting, Combs Andrew was the Chief Chemistry Officer of Prelude Therapeutics Inc. (stock ticker symbol PRLD).
Also see all insider trading activities at Prelude Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PRLD | 100,000 | $69,300 | 0 | $0 | 0 | $0 |
| 2022 | PRLD | 0 | $0 | 0 | $0 | 36,062 | $68,157 |
| 2021 | PRLD | 8,000 | $94,880 | 0 | $0 | 0 | $0 |
| 2020 | PRLD | 1,000 | $19,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-25 | PRLD | Buy | 100,000 | .69 | 69,300 |
| 2022-03-31 | PRLD | Option Ex | 36,062 | 1.89 | 68,157 |
| 2021-12-14 | PRLD | Buy | 4,000 | 11.60 | 46,400 |
| 2021-12-13 | PRLD | Buy | 4,000 | 12.12 | 48,480 |
| 2020-09-29 | PRLD | Buy | 1,000 | 19.00 | 19,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Combs Andrew (Chief Chemistry Officer of Prelude Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.